Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat |
| |
Authors: | E Ozyurt D I Graham G N Woodruff J McCulloch |
| |
Affiliation: | Wellcome Neuroscience Group, Wellcome Surgical Institute, University of Glasgow, United Kingdom. |
| |
Abstract: | The effects of the glutamate N-methyl-D aspartate (NMDA) receptor antagonist, MK-801, upon ischemic brain damage has been examined in anesthetized cats. Focal cerebral ischemia was produced by permanent occlusion of one middle cerebral artery and the animal were killed 6 h later. The amount of early ischemic damage was assessed in coronal sections at 16 predetermined stereotactic planes. Pretreatment with MK-801 (5 mg/kg, i.v.), 30 min before occlusion of the middle cerebral artery significantly reduced the volume of ischemic damage (from 32.7 +/- 4.0% of the cerebral hemisphere in vehicle-treated cats to 16.2 +/- 4.5% in MK-801-treated cats). NMDA receptor antagonists that penetrate the blood-brain barrier, such as MK-801, merit further study as protective agents against ischemic brain damage. |
| |
Keywords: | |
|
|